Clinical Impact of

Autor: Valentina, Fainardi, Chiara, Sodini, Michela, Deolmi, Andrea, Ciuni, Kaltra, Skenderaj, Maria Bice, Stabile, Cosimo, Neglia, Elena Mariotti, Zani, Cinzia, Spaggiari, Nicola, Sverzellati, Susanna, Esposito, Giovanna, Pisi
Rok vydání: 2022
Zdroj: Microorganisms. 10(4)
ISSN: 2076-2607
Popis: The clinical relevance of Aspergillus fumigatus (Af) in cystic fibrosis (CF) is controversial. The aims of the study were to assess the prevalence of Af disease in our cohort of CF patients and evaluate whether allergic bronchopulmonary aspergillosis (ABPA) and sensitization to Af affected lung function, body mass index (BMI) and exacerbations.Clinical data and lung function of CF patients aged 6-18 years followed at the CF Centre of Parma (Italy) were recorded. Patients were classified as: patients with no signs of Af, patients sensitized or colonized by Af, patients with ABPA or patients with Aspergillus bronchitis (Ab).Of 38 CF patients (14.2 years (6.2-18.8) M 23), 8 (21%) showed Af sensitization, 7 (18.4%) showed ABPA, 1 (2.6%) showed Af colonization and 1 (2.6%) showed Ab. Compared to non-ABPA, patients with ABPA had lower BMI (15.9 ± 1.6 vs. 19.7 ± 3.4,This study showed the relevant clinical impact of ABPA and Af sensitization in terms of exacerbations and lung structural damage.
Databáze: OpenAIRE